DWI und PET/MRT nach Strahlentherapie bei malignen Kopf-Hals-Tumoren

Interpreting imaging studies of the irradiated neck constitutes a challenge because of radiation therapy-induced tissue alterations, the variable appearances of recurrent tumors, and functional and metabolic phenomena that mimic disease. Therefore, morphologic magnetic resonance (MR) imaging, diffusion-weighted (DW) imaging, positron emission tomography with computed tomography (PET/CT), and software fusion of PET and MR imaging data sets are increasingly used to facilitate diagnosis in clinical practice. Because MR imaging and PET often yield complementary information, PET/MR imaging holds promise to facilitate differentiation of tumor recurrence from radiation therapy-induced changes and complications. This review focuses on clinical applications of DW and PET/MR imaging in the irradiated neck and discusses the added value of multiparametric imaging to solve diagnostic dilemmas. Radiologists should understand key features of radiation therapy-induced tissue alterations and potential complications seen at DW and PET/MR imaging, including edema, fibrosis, scar tissue, soft-tissue necrosis, bone and cartilage necrosis, cranial nerve palsy, and radiation therapy-induced arteriosclerosis, brain necrosis, and thyroid disorders. DW and PET/MR imaging also play a complementary role in detection of residual and recurrent disease. Interpretation pitfalls due to technical, functional, and metabolic phenomena should be recognized and avoided. Familiarity with DW and PET/MR imaging features of expected findings, potential complications, and treatment failure after radiation therapy increases diagnostic confidence when interpreting images of the irradiated neck. Online supplemental material is available for this article.

[1]  Sandra Nuyts,et al.  Detection of head and neck squamous cell carcinoma with diffusion weighted MRI after (chemo)radiotherapy: correlation between radiologic and histopathologic findings. , 2007, International journal of radiation oncology, biology, physics.

[2]  Valerie Duay,et al.  Segmentation of Head and Neck Lymph Node Regions for Radiotherapy Planning Using Active Contour-Based Atlas Registration , 2009, IEEE Journal of Selected Topics in Signal Processing.

[3]  A. King,et al.  MRI of radiation-induced tumors of the head and neck in post-radiation nasopharyngeal carcinoma , 2009, European Radiology.

[4]  R L Wahl,et al.  Pitfalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants. , 1999, Radiographics : a review publication of the Radiological Society of North America, Inc.

[5]  M. Kaplan,et al.  Clinical role of 18F-FDG PET/CT in the management of squamous cell carcinoma of the head and neck and thyroid carcinoma. , 2007, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[6]  James F Dempsey,et al.  Determination and delineation of nodal target volumes for head-and-neck cancer based on patterns of failure in patients receiving definitive and postoperative IMRT. , 2002, International journal of radiation oncology, biology, physics.

[7]  A. King,et al.  MRI findings in patients with severe trismus following radiotherapy for nasopharyngeal carcinoma , 2009, European Radiology.

[8]  M. Hier,et al.  Head and neck incidentalomas on positron emission tomographic scanning: ignore or investigate? , 2011, Journal of otolaryngology - head & neck surgery = Le Journal d'oto-rhino-laryngologie et de chirurgie cervico-faciale.

[9]  Michael K. Gupta,et al.  Meta-analysis The Proportion of Malignancy in Incidental Thyroid Lesions on 18-FDG PET Study : A Systematic , 2014 .

[10]  J. Modersitzki,et al.  Diffeomorphic susceptibility artifact correction of diffusion-weighted magnetic resonance images , 2012, Physics in medicine and biology.

[11]  A. King,et al.  Diffusion-weighted MR imaging in the head and neck. , 2012, Radiology.

[12]  M. Kono,et al.  Subcutaneous fibrosis after whole neck irradiation. , 2002, International journal of radiation oncology, biology, physics.

[13]  Hyun Soo Kim,et al.  A study on the artifacts generated by dental materials in PET/CT image , 2013, 2013 35th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC).

[14]  G. V. von Schulthess,et al.  PET/CT versus body coil PET/MRI: how low can you go? , 2013, Insights into Imaging.

[15]  L. F. Fajardo.  The pathology of ionizing radiation as defined by morphologic patterns* , 2005, Acta oncologica.

[16]  W. Bautz,et al.  MRI appearance of radiation-induced changes of normal cervical tissues , 2001, European Radiology.

[17]  K. Ang,et al.  The Shrinking Thyroid: How Does Thyroid Size Change Following Radiation Therapy for Laryngeal Cancer? , 2009, American Journal of Neuroradiology.

[18]  M. Tiemann,et al.  Lymphocyte subsets in irradiation‐induced sialadenitis of the submandibular gland , 2005, Histopathology.

[19]  Habib Zaidi,et al.  Clinical Assessment of MR-Guided 3-Class and 4-Class Attenuation Correction in PET/MR , 2015, Molecular Imaging and Biology.

[20]  Y. Paksoy,et al.  Role of diffusion weighted MR in the discrimination diagnosis of the cystic and/or necrotic head and neck lesions. , 2007, European journal of radiology.

[21]  Karl-Olof Lovblad,et al.  Functional imaging of head and neck squamous cell carcinoma with diffusion-weighted MRI and FDG PET/CT: quantitative analysis of ADC and SUV , 2013, European Journal of Nuclear Medicine and Molecular Imaging.

[22]  A. King,et al.  T2-Weighted MR Imaging Early after Chemoradiotherapy to Evaluate Treatment Response in Head and Neck Squamous Cell Carcinoma , 2013, American Journal of Neuroradiology.

[23]  Cheng-Yu Chen,et al.  Necrotic nasopharyngeal mucosa: an ominous MR sign of a carotid artery pseudoaneurysm. , 2005, AJNR. American journal of neuroradiology.

[24]  A. Ozonoff,et al.  Use of 18F-FDG PET/CT as a predictive biomarker of outcome in patients with head-and-neck non-squamous cell carcinoma. , 2011, AJR. American journal of roentgenology.

[25]  N. Futran,et al.  Osteoradionecrosis of the mandible , 2005, Current opinion in otolaryngology & head and neck surgery.

[26]  M. Lapeyre,et al.  Délinéation des volumes cibles des cancers des voies aérodigestives supérieures en radiothérapie conformationnelle avec modulation d’intensité , 2011 .

[27]  Minerva Becker,et al.  Dedifferentiated laryngeal chondrosarcoma: Combined morphologic and functional imaging with positron‐emission tomography/magnetic resonance imaging , 2014, The Laryngoscope.

[28]  Daniel U. Campos-Delgado,et al.  Non-rigid multimodal image registration based on local variability measures and optical flow , 2012, 2012 Annual International Conference of the IEEE Engineering in Medicine and Biology Society.

[29]  R. Scher,et al.  Clinical implications of radionecrosis to the head and neck surgeon , 2003, Current opinion in otolaryngology & head and neck surgery.

[30]  H. Thoeny,et al.  Diffusion-weighted MR imaging including bi-exponential fitting for the detection of recurrent or residual tumour after (chemo)radiotherapy for laryngeal and hypopharyngeal cancers , 2013, European Radiology.

[31]  T. Hyslop,et al.  Pretreatment FDG‐PET standardized uptake value as a prognostic factor for outcome in head and neck cancer , 2009, Head & neck.

[32]  Habib Zaidi,et al.  Detection and quantification of focal uptake in head and neck tumours: 18F-FDG PET/MR versus PET/CT , 2013, European Journal of Nuclear Medicine and Molecular Imaging.

[33]  W. Bautz,et al.  Head and neck tumors: imaging recurrent tumor and post-therapeutic changes with CT and MRI. , 2000, European journal of radiology.

[34]  A. Alavi,et al.  Applications of fluorodeoxyglucose-PET imaging in the detection of infection and inflammation and other benign disorders. , 2005, Radiologic clinics of North America.

[35]  A. Garden,et al.  Benign Ulceration as a Manifestation of Soft Tissue Radiation Necrosis: Imaging Findings , 2008, American Journal of Neuroradiology.

[36]  Barton F Branstetter,et al.  Combined PET-CT in the head and neck: part 1. Physiologic, altered physiologic, and artifactual FDG uptake. , 2005, Radiographics : a review publication of the Radiological Society of North America, Inc.

[37]  M. Werner,et al.  Nonspecific FDG uptake in the tongue mimicking the primary tumor in a patient with cancer of unknown primary. , 2011, Clinical imaging.

[38]  N. Schwenzer,et al.  A strategy for multimodal deformable image registration to integrate PET/MR into radiotherapy treatment planning , 2013, Acta oncologica.

[39]  M. Ravanelli,et al.  Treatment monitoring of paranasal sinus tumors by magnetic resonance imaging , 2010, Cancer imaging : the official publication of the International Cancer Imaging Society.

[40]  J. Lefebvre.  Laryngeal preservation in head and neck cancer: multidisciplinary approach. , 2006, The Lancet. Oncology.

[41]  Yuka Yamamoto,et al.  Head and neck cancer: dedicated FDG PET/CT protocol for detection--phantom and initial clinical studies. , 2007, Radiology.

[42]  J. M. Debnam.  Imaging of the Head and Neck following Radiation Treatment , 2011, Pathology research international.

[43]  M. Reiser,et al.  18F-FDG PET/CT Identifies Patients at Risk for Future Vascular Events in an Otherwise Asymptomatic Cohort with Neoplastic Disease , 2009, Journal of Nuclear Medicine.

[44]  S. Fakhran,et al.  Osteoradionecrosis after Radiation Therapy for Head and Neck Cancer: Differentiation from Recurrent Disease with CT and PET/CT Imaging , 2014, American Journal of Neuroradiology.

[45]  M. Marzola,et al.  Evaluation of incidentally discovered adrenal masses with PET and PET/CT. , 2012, European journal of radiology.

[46]  K. Wallston,et al.  Prevalence of secondary lymphedema in patients with head and neck cancer. , 2012, Journal of Pain and Symptom Management.

[47]  K. Higgins,et al.  Osteoradionecrosis of the mandible: a case series at a single institution , 2013, Journal of Otolaryngology - Head & Neck Surgery.

[48]  W. Smoker,et al.  Pathologic conditions of the lower cranial nerves IX, X, XI, and XII. , 2008, Neuroimaging clinics of North America.

[49]  R. Sun,et al.  Clinical findings and imaging features of 67 nasopharyngeal carcinoma patients with postradiation nasopharyngeal necrosis , 2013, Chinese journal of cancer.

[50]  O. Ratib,et al.  FDG-PET/CT pitfalls in oncological head and neck imaging , 2014, Insights into Imaging.

[51]  E. Genden,et al.  The Significance and Management of Incidental [18F]Fluorodeoxyglucose–Positron-Emission Tomography Uptake in the Thyroid Gland in Patients with Cancer , 2009, American Journal of Neuroradiology.

[52]  Niamh M. Long,et al.  Causes and imaging features of false positives and false negatives on 18F-PET/CT in oncologic imaging , 2011, Insights into imaging.

[53]  R. Hermans,et al.  Applications of diffusion-weighted magnetic resonance imaging in head and neck squamous cell carcinoma , 2010, Neuroradiology.

[54]  Yao-pan Wu,et al.  CT and MRI of radiation-induced sarcomas of the head and neck following radiotherapy for nasopharyngeal carcinoma. , 2013, Clinical radiology.

[55]  Habib Zaidi,et al.  Novel quantitative techniques for assessing regional and global function and structure based on modern imaging modalities: implications for normal variation, aging and diseased states. , 2007, Seminars in nuclear medicine.

[56]  C Norman Coleman,et al.  Effects of radiation on normal tissue: consequences and mechanisms. , 2003, The Lancet. Oncology.

[57]  P. Richards,et al.  The role of ultrasound in the detection of cervical lymph node metastases in clinically N0 squamous cell carcinoma of the head and neck , 2007, Cancer imaging : the official publication of the International Cancer Imaging Society.

[58]  Seong-Jang Kim,et al.  Factors associated with the development of new onset diffuse thyroid F18-fluorodeoxyglucose uptake after treatment of breast cancer in patients without a history of thyroid disease or thyroid dysfunction. , 2012, Thyroid : official journal of the American Thyroid Association.

[59]  Hon-Man Liu,et al.  Osteoradionecrosis of the upper cervical spine after radiation therapy for head and neck cancer: differentiation from recurrent or metastatic disease with MR imaging. , 2012, Radiology.

[60]  M. Viallon,et al.  Imaging of the optic nerve. , 2010, European journal of radiology.

[61]  H. Curtin.  The "evil gray": cancer and cartilage. , 2008, Radiology.

[62]  Osman Ratib,et al.  Approaches for the optimization of MR protocols in clinical hybrid PET/MRI studies , 2013, Magnetic Resonance Materials in Physics, Biology and Medicine.

[63]  R. Hayden,et al.  Neck neoplasms: MR imaging. Part II. Posttreatment evaluation. , 1986, Radiology.

[64]  A. Razek,et al.  Role of Diffusion-Weighted Echo-Planar MR Imaging in Differentiation of Residual or Recurrent Head and Neck Tumors and Posttreatment Changes , 2007, American Journal of Neuroradiology.

[65]  M. Nakahira,et al.  Posttreatment CT and MR imaging in head and neck cancer: what the radiologist needs to know. , 2012, Radiographics : a review publication of the Radiological Society of North America, Inc.

[66]  Y. Erdi,et al.  18F-FDG PET/CT for detecting nodal metastases in patients with oral cancer staged N0 by clinical examination and CT/MRI. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[67]  H. Danesh-Meyer.  Radiation-induced optic neuropathy , 2008, Journal of Clinical Neuroscience.

[68]  H. Thoeny.  Diffusion-weighted MRI in head and neck radiology: applications in oncology , 2011, Cancer imaging : the official publication of the International Cancer Imaging Society.

[69]  Françoise Kraeber-Bodéré,et al.  Does 18F-FDG PET/CT Improve the Detection of Posttreatment Recurrence of Head and Neck Squamous Cell Carcinoma in Patients Negative for Disease on Clinical Follow-up? , 2008, Journal of Nuclear Medicine.

[70]  S. Mukherji,et al.  Evaluation of head and neck squamous cell carcinoma after treatment. , 2003, AJNR. American journal of neuroradiology.

[71]  Y.J. Kim,et al.  Differentiation of Recurrent Tumor and Posttreatment Changes in Head and Neck Squamous Cell Carcinoma: Application of High b-Value Diffusion-Weighted Imaging , 2013, American Journal of Neuroradiology.

[72]  Mithat Gonen,et al.  Diagnostic and Prognostic Value of [18F]Fluorodeoxyglucose Positron Emission Tomography for Recurrent Head and Neck Squamous Cell Carcinoma , 2002 .

[73]  S. Schoenberg,et al.  Current oncologic concepts and emerging techniques for imaging of head and neck squamous cell cancer , 2012, GMS current topics in otorhinolaryngology, head and neck surgery.

[74]  H. Bartelink,et al.  Increased carotid wall thickening after radiotherapy on the neck. , 2005, European journal of cancer.

[75]  T. Turkington,et al.  Analysis of pretreatment FDG-PET SUV parameters in head-and-neck cancer: tumor SUVmean has superior prognostic value. , 2012, International journal of radiation oncology, biology, physics.

[76]  K. Luk,et al.  Cervical spine complications after treatment of nasopharyngeal carcinoma , 2013, European Spine Journal.

[77]  W. Mendenhall,et al.  CT findings in chondroradionecrosis of the larynx. , 1998, AJNR. American journal of neuroradiology.

[78]  S. Larson,et al.  Clinical Utility of 18F-FDG PET/CT in Assessing the Neck After Concurrent Chemoradiotherapy for Locoregional Advanced Head and Neck Cancer , 2008, Journal of Nuclear Medicine.

[79]  M. Nomoto,et al.  FDG PET/CT and Diffusion-Weighted Imaging of Head and Neck Squamous Cell Carcinoma: Comparison of Prognostic Significance Between Primary Tumor Standardized Uptake Value and Apparent Diffusion Coefficient , 2012, Clinical nuclear medicine.

[80]  Surjith Vattoth,et al.  Radiation necrosis in the brain: imaging features and differentiation from tumor recurrence. , 2012, Radiographics : a review publication of the Radiological Society of North America, Inc.

[81]  Piotr J. Slomka,et al.  Multimodality image registration with software: state-of-the-art , 2009, European Journal of Nuclear Medicine and Molecular Imaging.

[82]  T. Hany,et al.  Is there a correlation between 18F-FDG-PET standardized uptake value, T-classification, histological grading and the anatomic subsites in newly diagnosed squamous cell carcinoma of the head and neck? , 2010, European Archives of Oto-Rhino-Laryngology.

[83]  J. Buatti,et al.  Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience. , 2005, International journal of radiation oncology, biology, physics.

[84]  C. Czerny,et al.  Functional imaging in head and neck squamous cell carcinoma: correlation of PET/CT and diffusion-weighted imaging at 3 Tesla , 2011, European Journal of Nuclear Medicine and Molecular Imaging.

[85]  Jing Yuan,et al.  Head and neck squamous cell carcinoma: diagnostic performance of diffusion-weighted MR imaging for the prediction of treatment response. , 2013, Radiology.

[86]  A. Shaha.  Systematic Management of Osteoradionecrosis in the Head and Neck , 1999 .

[87]  J. Curschmann,et al.  Radionecrosis or tumor recurrence after radiation of laryngeal and hypopharyngeal carcinomas , 2005, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[88]  B. Yap,et al.  Thyroid incidentalomas discovered on positron emission tomography CT scanning - Malignancy rate and significance of standardised uptake values. , 2014, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[89]  M. Karamouzis,et al.  Head and neck cancer , 2008, The Lancet.

[90]  G. Schroth,et al.  Long-term changes induced by high-dose irradiation of the head and neck region: imaging findings. , 1997, Radiographics : a review publication of the Radiological Society of North America, Inc.

[91]  T. Mikkelsen,et al.  Treatment induced necrosis versus recurrent/progressing brain tumor: going beyond the boundaries of conventional morphologic imaging , 2010, Journal of Neuro-Oncology.

[92]  S. Adak,et al.  Hypothyroidism incidence after multimodality treatment for stage III and IV squamous cell carcinomas of the head and neck. , 2001, International Journal of Radiation Oncology, Biology, Physics.

[93]  Jonathan R. Clark,et al.  Quantifying fibrosis in head and neck cancer treatment: An overview , 2015, Head & neck.

[94]  H. Nabi,et al.  18F-FDG imaging: pitfalls and artifacts. , 2005, Journal of nuclear medicine technology.

[95]  Sanjeev Chawla,et al.  Diffusion-weighted imaging in head and neck cancers. , 2009, Future oncology.

[96]  P. Scolozzi,et al.  Radiolucent lesions of the mandible: a pattern-based approach to diagnosis , 2013, Insights into Imaging.

[97]  B. Vikram,et al.  Intensity-modulated radiation therapy for head and neck cancer: emphasis on the selection and delineation of the targets. , 2002, Seminars in radiation oncology.

[98]  P. Dulguerov,et al.  Neoplastic invasion of laryngeal cartilage: reassessment of criteria for diagnosis at MR imaging. , 2008, Radiology.

[99]  Wolfgang A. Tome,et al.  Emphasizing conformal avoidance versus target definition for IMRT planning in head-and-neck cancer. , 2010, International journal of radiation oncology, biology, physics.

[100]  S. Yang,et al.  Utility of TL‐201 SPECT in clarifying false‐positive FDG‐PET findings due to osteoradionecrosis in head and neck cancer , 2010, Head & neck.

[101]  Prescribing, Recording, and Reporting Photon-Beam Intensity-Modulated Radiation Therapy (IMRT) , 2010, Journal of the ICRU.

[102]  Wen-Sheng Huang,et al.  Early radiation-induced bone marrow injury: serial MR imaging during initial 4 weeks after irradiation. , 2009, Academic radiology.

[103]  Quanzheng Li,et al.  Magnetic resonance-based motion correction for positron emission tomography imaging. , 2013, Seminars in nuclear medicine.

[104]  Sandra Nuyts,et al.  Diffusion-weighted magnetic resonance imaging early after chemoradiotherapy to monitor treatment response in head-and-neck squamous cell carcinoma. , 2012, International journal of radiation oncology, biology, physics.

[105]  S. Stoeckli,et al.  Thyroid incidentalomas in FDG-PET/CT: prevalence and clinical impact , 2012, European Archives of Oto-Rhino-Laryngology.

[106]  M. Uder,et al.  Comparison of lesion detection and quantitation of tracer uptake between PET from a simultaneously acquiring whole-body PET/MR hybrid scanner and PET from PET/CT , 2012, European Journal of Nuclear Medicine and Molecular Imaging.

[107]  A. Alavi,et al.  Complementary Roles of Whole-Body Diffusion-Weighted MRI and 18F-FDG PET: The State of the Art and Potential Applications , 2010, The Journal of Nuclear Medicine.

[108]  Habib Zaidi,et al.  Imaging in head and neck squamous cell carcinoma: the potential role of PET/MRI , 2014, The British journal of radiology.

[109]  J. Roodenburg,et al.  18F-FDG PET as a Routine Posttreatment Surveillance Tool in Oral and Oropharyngeal Squamous Cell Carcinoma: A ProspectiveStudy , 2009, Journal of Nuclear Medicine.

[110]  S. Nehmeh,et al.  Respiratory motion in positron emission tomography/computed tomography: a review. , 2008, Seminars in nuclear medicine.

[111]  Michael K. Gupta,et al.  The Proportion of Malignancy in Incidental Thyroid Lesions on 18-FDG PET Study , 2014, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[112]  Zhang Xiong-wei,et al.  Combined application of 18F-fluorodeoxyglucose positron emission tomography/computed tomography and magnetic resonance imaging in early diagnosis of vulnerable carotid atherosclerotic plaques , 2014, The Journal of international medical research.

[113]  K. Chang,et al.  Correlation of 18F-FDG Uptake with Apparent Diffusion Coefficient Ratio Measured on Standard and High b Value Diffusion MRI in Head and Neck Cancer , 2011, The Journal of Nuclear Medicine.

[114]  D. O'mahony,et al.  The role of the breast radiologist in evaluation of breast incidentalomas detected on 18-fludeoxyglucose positron emission tomography/CT. , 2013, The British journal of radiology.

[115]  Joshua D. Lawson,et al.  Prospective study of functional bone marrow-sparing intensity modulated radiation therapy with concurrent chemotherapy for pelvic malignancies. , 2013, International journal of radiation oncology, biology, physics.

[116]  Jun Shen,et al.  Late-onset radiation-induced optic neuropathy after radiotherapy for nasopharyngeal carcinoma , 2013, Journal of Clinical Neuroscience.

[117]  Steve Williamson,et al.  Effect of Surgery on Normal Tissue Toxicity in Patients Treated with Accelerated Radiotherapy , 2002, Acta oncologica.

[118]  R. Corvò.  Evidence-based radiation oncology in head and neck squamous cell carcinoma. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[119]  R. Hustinx,et al.  PET/CT in head and neck cancer: an update , 2010, European Journal of Nuclear Medicine and Molecular Imaging.

[120]  A. Christe,et al.  Pretherapeutic Staging of Recurrent Laryngeal Carcinoma: Clinical Findings and Imaging Studies Compared with Histopathology , 2007, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.